10 Lymphoma Clinical Trials in Bethesda, MD (2026)

Q: How do I join a clinical trial in Bethesda?

Browse available studies, click one that interests you, and complete the free eligibility form. A study coordinator at the Bethesda research site will contact you.

Recruiting Lymphoma Studies in Bethesda

NCT05170399Recruiting

Vaccine Responses in Patients With B Cell Malignancies

Background: People with B cell malignancies (blood cancers) often cannot mount a full immune response to infections or certain vaccines. Bruton tyrosine kinase inhibitors (BTKis), which are used to t...

Bethesda, MDPHASE4350 participantsNational Heart, Lung, and Blood Institute (NHLBI)

View Study Details

NCT07652580Recruiting

Toxin Exposure and Immune Dysregulation in Non-Hodgkin Lymphoma

The goal of this observational cohort study is to learn how toxin and occupational exposures, germline genetic variation, and immune dysregulation relate to B-cell non-Hodgkin lymphoma among active-du...

Bethesda, MD300 participantsHenry M. Jackson Foundation for the Advancement of Military Medicine

View Study Details

NCT03190928Recruiting

Clonal Evolution in Follicular Lymphoma

Background: Follicular lymphoma is a type of cancer of the lymph nodes. Lab studies are important for cancer research. They help scientists better understand differences in the cancer biology of diff...

Bethesda, MD200 participantsNational Cancer Institute (NCI)

View Study Details

NCT03223610Recruiting

Venetoclax, Ibrutinib, Prednisone, Obinutuzumab, and Revlimid (ViPOR) in Relapsed/Refractory B-cell Lymphoma

Background: B-cell lymphoma is a cancer of white blood cells found in the lymph nodes. It affects the system that fights infections and disease. Researchers want to learn how certain drugs work toget...

Bethesda, MDPHASE1155 participantsNational Cancer Institute (NCI)

View Study Details

NCT04002947Recruiting

Acalabrutinib With DA-EPOCH-R or R-CHOP for People With Untreated Diffuse Large B-cell Lymphoma

Background: Diffuse large B-cell lymphoma is the most common type of non-Hodgkin lymphoma. Most people with this cancer can be cured. But those who are not cured have a poor prognosis. Researchers wa...

Bethesda, MDPHASE2132 participantsNational Cancer Institute (NCI)

View Study Details

NCT05442515Recruiting

CD19/CD22 Bicistronic Chimeric Antigen Receptor (CAR) T Cells in Children and Young Adults With Recurrent or Refractory B Cell Malignancies

Background: Acute lymphoblastic leukemia (ALL) is the most common cancer in children. About 90% of children and young adults who are treated for ALL can now be cured. But if the disease comes back, t...

Bethesda, MDPHASE1130 participantsNational Cancer Institute (NCI)

View Study Details

NCT06223542Recruiting

Studying TAK-243 in Patients With Advanced Cancer

This phase I trial studies the side effects and best dose of ubiquitin-activating enzyme (UAE) inhibitor TAK-243 (TAK-243) in treating patients with a solid tumor that may have spread from where it fi...

Bethesda, MDPHASE195 participantsNational Cancer Institute (NCI)

View Study Details

NCT05237986Recruiting

Cognitive Aftereffects of Neurotoxicity in Children and Young Adults With Relapsed/Refractory Hematologic Malignancies Who Receive CAR T-cell Therapy

Background: CAR T-cell therapy is a promising new treatment for blood cancers. During treatment, a person s T-cells are genetically changed to kill cancer cells. Researchers want to learn more about ...

Bethesda, MD60 participantsNational Cancer Institute (NCI)

View Study Details

NCT05907759Recruiting

Daratumumab for Relapsed/Refractory Primary Effusion Lymphoma, Plasmablastic Lymphoma, and Multicentric Castleman Disease

Background: Primary effusion lymphoma (PEL), plasmablastic lymphoma (PBL), and Multicentric Castleman Disease (MCD) are aggressive forms of cancer that affects cells in the immune system and lymph no...

Bethesda, MDPHASE228 participantsNational Cancer Institute (NCI)

View Study Details

NCT05389423Recruiting

Pomalidomide and Dose-Adjusted EPOCH +/- Rituximab for HIV-Associated Lymphomas

Background: Non-Hodgkin lymphoma (NHL) is the most common cancer among people living with HIV in the United States. People with HIV are up to 17 times more likely to get NHL than people who do not ha...

Bethesda, MDPHASE125 participantsNational Cancer Institute (NCI)

View Study Details

About Lymphoma Clinical Trials in Bethesda

Lymphoma is a cancer of the lymphatic system that affects infection-fighting cells called lymphocytes. The two main types are Hodgkin lymphoma and non-Hodgkin lymphoma. Treatment often includes chemotherapy, radiation, immunotherapy, and in some cases stem cell transplant.

There are currently 10 lymphoma clinical trials recruiting participants in Bethesda, MD. These studies are seeking a combined 1,475 participants. Research is being sponsored by National Heart, Lung, and Blood Institute (NHLBI), Henry M. Jackson Foundation for the Advancement of Military Medicine, National Cancer Institute (NCI). Clinical trial participation is free and participants receive study-related medical care at no cost.

Lymphoma Clinical Trials in Bethesda — FAQ

Are there lymphoma clinical trials in Bethesda?

Yes, there are 10 lymphoma clinical trials currently recruiting in Bethesda, MD. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Bethesda?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Bethesda research site will contact you about next steps.

Are clinical trials in Bethesda free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Bethesda studies also compensate for your time and travel.

What lymphoma treatments are being tested?

The 10 active trials in Bethesda are testing new therapies including novel drugs, biologics, and treatment approaches for lymphoma.

Data updated September 3, 2026 from ClinicalTrials.gov